Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 129 (RN7SKP129) is a pseudogene, meaning it is a genomic DNA sequence similar to a functional gene (the RNA, 7SK small nuclear RNA gene, or RN7SK) but is generally non-functional and does not produce a functional product[3][7]. Pseudogenes like RN7SKP129 typically arise from gene duplication or retrotransposition events and accumulate mutations that prevent their transcription or translation. There is no evidence that RN7SKP129 acts as a therapeutic target, is involved in any known biological processes, or has any known disease associations, biomarker, or pharmacological relevance. RN7SKP129 is not considered a therapeutic target and should not be confused with the functional non-coding RNA, RN7SK. There is nothing misspelled in the designation, but it is not a druggable target, receptor, or functional molecule, and so would be labeled "incorrect" for most drug discovery or biological targeting contexts[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 129 (RN7SKP129).